Multiple flow rate modelling of nitric oxide in COPD – methodological concerns

Por Kay Roy, Zoe Borrill, Andrew Hazel, Jorgen Vestbo, Dave Singh
Publicado em 2006-12-01

The global impact of Aspergillus infection on COPD

Por Emily E. Hammond, Charles S. McDonald, Jørgen Vestbo, David W. Denning
Publicado em 2020-09-01

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials

Por Alexander G. Mathioudakis, Mia Moberg, Julie Janner, Pablo Alonso-Coello, Jørgen Vestbo
Publicado em 2019-05-01

COPD monocytes demonstrate impaired migratory ability

Por Arjun K Ravi, Jonathan Plumb, Rosemary Gaskell, Sarah Mason, Caroline S Broome, George Booth, Matthew Catley, Jørgen Vestbo, Dave Singh
Publicado em 2017-05-01

Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions.

Por Helle Wulf-Johansson, Sofie Lock Johansson, Anders Schlosser, Anne Trommelholt Holm, Lars Melholt Rasmussen, Hans Mickley, Axel C P Diederichsen, Henrik Munkholm, Tina Svenstrup Poulsen, Ida Tornøe, Vicki Nielsen, Niels Marcussen, Jørgen Vestbo, Susanne Gjørup Sækmose, Uffe Holmskov, Grith Lykke Sorensen
Publicado em 2013-01-01

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

Por Seonaidh Cotton, Graham Devereux, Hassan Abbas, Andrew Briggs, Karen Campbell, Rekha Chaudhuri, Gourab Choudhury, Dana Dawson, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Chim C. Lang, Amanda J. Lee, Graeme MacLennan, William MacNee, Kirsty McCormack, Nicola McMeekin, Nicholas L. Mills, Alyn Morice, John Norrie, Mark C. Petrie, David Price, Philip Short, Jorgen Vestbo, Paul Walker, Jadwiga Wedzicha, Andrew Wilson, Brian J. Lipworth
Publicado em 2022-04-01